NLRP3 and acute kidney injury: demonstrated that NLRP3 knockout mice were resistant to ischemia–reperfusion injury (IRI)-induced AKI; however, in cisplatin-induced AKI, NLRP3 deficiency did not reduce caspase-1 levels.